Skip to content
DataLookout
Menu

NCT06575699

Rectus Sheath Block for Analgesia After Gynecological Laparotomy

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 19, 2026
    • Eligibility criteria expanded, about 6 words
    • Primary endpoint revised
    • Secondary endpoints revised (14)
  2. Minor Trial status: Recruiting to Completed
    • Primary and study completion dates changed from estimate of Jan 2026 to Nov 28, 2025
    • Site details revised
    v4
  3. Minor Primary and study completion dates: Dec 2025 to Jan 2026v3
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2024 to Oct 10, 2024
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Postoperative Opioid Consumption 0 to 72 Hours After Surgery
Timeframe: 0-72 hours after time 0 (end of surgery)

Secondary (14)

Total Postsurgical Opioid Consumption at 0-24, 24-48, and 48-72 Hours
Number of Participants With Intraoperative Hypotension
Number of Participants With Postoperative Hypotension
Number of Participants Receiving Rescue Antiemetics
Number of Participants Receiving Rescue Antipruritics
Show 9 moreShow less
Number of Participants Developing Ileus or Constipation
Number of Participants With Respiratory Depression
Area Under the Curve (AUC) of Visual Analog Scale (VAS) Pain Intensity Scores Through 72 Hours (AUC 0-72)
Maximum Pain Scores Reported
Time to Mobilization
Time to Urinary Catheter Removal
Duration of Post Anesthesia Care Unit (PACU) Stay
Duration of Hospital Stay
Number of Participants Receiving Intraoperative Vasopressors

Arms and interventions

Rectus Sheath Block Group (Prospective arm)Experimental

Thirty subjects will be prospectively enrolled and will receive a bilateral rectus sheath block under ultrasound guidance using 133 mg liposomal bupivacaine and 20 ml bupivacaine 0.25% per side.

Thoracic Epidural Analgesia Group (retrospective arm)Active comparator

60 patients who received thoracic epidural analgesia as part of our enhanced recovery after surgery protocol and stayed in hospital for at least 72 h.

Procedures: Rectus sheath block, Thoracic Epidural Analgesia

Drugs: Liposomal bupivacaine, Bupivacaine Hydrochloride, Bupivacaine-Hydromorphone Cassette

Sites

1 site in 1 country

  • Duke University Medical CenterDurham, North Carolina, United States